TELA Bio, Inc. (NASDAQ:TELA) CEO Purchases $49,940.00 in Stock

TELA Bio, Inc. (NASDAQ:TELA – Get Free Report) CEO Antony Koblish acquired 11,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 14th. The shares were purchased at an average cost of $4.54 per share, with a total value of $49,940.00. Following the completion of the acquisition, the chief executive officer […]

Related Keywords

New York ,United States ,Antony Koblish ,Tela Bio Inc ,Calamos Advisors ,Century Growth Investors ,Nasdaq ,Jacob Asset Management Of New York ,Sbio Company Profile ,Securities Exchange Commission ,Sectoral Asset Management Inc ,Bio Inc ,Cm Wealth Advisors ,Get Free Report ,Exchange Commission ,Asset Management ,Sectoral Asset Management ,Ovitex Reinforced Tissue Matrix ,Tissue Matrix ,Robotic Procedures ,Tela Bio ,Nasdaq Tela ,Tutela ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,